Serum β-Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis

Figure 4

Univariate correlation (Spearman analysis) between β-catenin and sclerostin serum levels in PMOP patients ((a) 𝑟=−0.400, 𝑃<0.001) and controls ((b) 𝑟=0.145, 𝑃=0.060).

(a)

(b)